An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
The new centre will comprise a team of 50 highly experienced specialists
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
The hospital has recently launched Radionuclide therapy
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Rajiv Gandhi Cancer Institute (RGCI), Delhi one of Asia’s premier institutes becomes the first strategic partner to adopt and implement Project Chariot in patients across North India & Delhi NCR region
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Subscribe To Our Newsletter & Stay Updated
